Sort   by:  
 Page size 
UnknownIn vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject.
Not available
S-EPMC2519584 | biostudies-literature
UnknownPreferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments.
Not available
S-EPMC9402695 | biostudies-literature
UnknownChanges in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy.
Not available
S-EPMC3689341 | biostudies-literature
UnknownHost-dependent trigger of caspases and apoptosis by Legionella pneumophila.
Not available
S-EPMC1932860 | biostudies-literature
UnknownConstructing Antiretroviral Supramolecular Polymers as Long-Acting Injectables through Rational Design of Drug Amphiphiles with Alternating Antiretroviral-Based and Hydrophobic Residues.
Not available
S-EPMC11044016 | biostudies-literature
UnknownBiphasic elimination of tenofovir diphosphate and nonlinear pharmacokinetics of zidovudine triphosphate in a microdosing study.
Not available
S-EPMC3509498 | biostudies-literature
UnknownLong-acting drugs and formulations for the treatment and prevention of HIV infection.
Not available
S-EPMC7790856 | biostudies-literature
UnknownRacial differences in response to antiretroviral therapy for HIV infection: an AIDS clinical trials group (ACTG) study analysis.
Not available
S-EPMC3814827 | biostudies-literature
UnknownPredicting Pharmacokinetics of a Tenofovir Alafenamide Subcutaneous Implant Using Physiologically Based Pharmacokinetic Modelling.
Not available
S-EPMC7526822 | biostudies-literature
UnknownNutrient intakes and top food categories contributing to intakes of energy and nutrients-of-concern consumed by Canadian adults that would require a 'high-in' front-of-pack symbol according to Canadian labelling regulations.
Not available
S-EPMC10194982 | biostudies-literature
Sort   by:  
 Page size